Metabolic Disorders Completed Phase 3 Trials for Mipomersen (DB05528)

Back to Metabolic Disorders

Also known as: Metabolic Disorder / Metabolic disorder, unspecified / Metabolic disorder NOS / Generalized metabolic disorder (disorder) / Unspecified disorder of metabolism / Metabolic disease (disorder) / Metabolic Diseases

IndicationStatusPhase
DBCOND0035995 (Metabolic Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00694109
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-HypercholesterolemiaTreatment
NCT00607373
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial HypercholesterolemiaTreatment